Leef Brands (LEEEF) EPS (Basic) (2025 - 2026)
Leef Brands (LEEEF) posted EPS (Basic) of -$0.0 for Q1 2026, down 207.89% sequentially from $0.0 in Q1 2025, and down 207.89% YoY from $0.0 in Q1 2025.
Leef Brands (LEEEF) EPS (Basic) (2025 - 2026) Analysis & Trends
Leef Brands has reported EPS (Basic) for 2 years, with the latest figure at -$0.0 in Q1 2026.
- Quarterly EPS (Basic) fell 207.89% year-over-year to -$0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.0 (changed N/A YoY) and the FY2025 annual result came in at -$0.1, up 45.07% from the prior year.
- EPS (Basic) retreated to -$0.0 in Q1 2026 per LEEEF's latest filing, from $0.0 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.0 in Q1 2025 and troughed at -$0.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Mar 31, 2026 | 0.00 |
| Mar 31, 2025 | 0.00 |